Detalles de la búsqueda
1.
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
Chemotherapy
; 67(3): 142-151, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313303
2.
Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.
Oncology
; 99(9): 562-570, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237736
3.
Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.
Medicina (Kaunas)
; 57(9)2021 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34577852
4.
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101.
Int J Clin Oncol
; 25(5): 867-875, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32060768
5.
Effects of Proton Pump Inhibitor Coadministration on the Plasma Concentration of Erlotinib in Patients With Non-Small Cell Lung Cancer.
Ther Drug Monit
; 40(6): 699-704, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29995672
6.
Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors.
Chemotherapy
; 63(3): 181-189, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30107372
7.
A Simple High-Performance Liquid Chromatography for Determining Lapatinib and Erlotinib in Human Plasma.
Ther Drug Monit
; 38(6): 657-662, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27851685
8.
Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer.
Anticancer Res
; 44(6): 2725-2730, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38821613
9.
Disseminated cryptococcosis in a geriatric man following high-dose systemic steroid therapy for severe COVID-19 pneumonia.
J Gen Fam Med
; 24(6): 350-351, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38025929
10.
Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321.
Cancer Med
; 12(14): 14988-14999, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37226421
11.
Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI).
In Vivo
; 37(5): 2203-2209, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37652502
12.
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI).
Anticancer Res
; 43(10): 4583-4591, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772562
13.
Stereotactic Body Radiotherapy for Stage I Lung Cancer With a New Real-time Tumor Tracking System.
Anticancer Res
; 42(6): 2989-2995, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641279
14.
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.
Thorac Cancer
; 13(19): 2776-2785, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36062426
15.
Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for EGFR-mutated Non-small Cell Lung Cancer.
Anticancer Res
; 42(5): 2583-2590, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489768
16.
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.
Front Oncol
; 12: 1080729, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36741711
17.
Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.
Cancer Med
; 10(20): 6971-6984, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34414673
18.
A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632.
Lung Cancer
; 161: 49-54, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34536731
19.
Prognostic value of morphological characteristics assessed by CT scan in patients with non-small cell lung cancer treated with nivolumab.
Thorac Cancer
; 11(12): 3521-3527, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33044045
20.
Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.
Thorac Cancer
; 11(10): 2867-2876, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32844570